Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)

China flag China · Delayed Price · Currency is CNY
10.24
-0.03 (-0.29%)
Jul 29, 2026, 3:00 PM CST
Market Cap6.39B -27.3%
Revenue (ttm)1.03B -5.7%
Net Income22.53M -91.1%
EPS0.04 -91.0%
Shares Out 623.76M
PE Ratio281.70
Forward PEn/a
Dividend0.14 (1.32%)
Ex-Dividend DateJun 17, 2026
Volume9,629,874
Open10.37
Previous Close10.27
Day's Range10.08 - 10.42
52-Week Range9.61 - 19.11
Beta0.51
Analystsn/a
Price Targetn/a
Earnings DateAug 22, 2026

About SHA:688553

Sichuan Huiyu Pharmaceutical Co., Ltd. researches, develops, produces, and sells anti-tumor injection in China and internationally. It offers injection drug products, such as pemetrexed disodium, methrotrexate, docetaxel, azacitidine, oxaliplatin, cyclophosphamide, irinotecan hydrochloride, paclitaxel, bendamustine hydrochloride, decitabine, palonosetron hydrochloride, plerixafor, levetiracetam concentrated solution, amifostine, levofolate calcium, thiotepa, fulvestrant, and milrinone drugs. The company also offers moroxydine sodium chloride, f... [Read more]

Sector Healthcare
Founded 2010
Employees 1,366
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688553
Full Company Profile

Financial Performance

Financial Statements